1 |
Engel H, Steinert H, Buck A, Berthold T, Rahel A, von Schulthess GK: Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations, J Nucl Med , 37, 441-6, 1996
|
2 |
Strauss LG: Fluorine-18 deoxyglucose and falsepositive results: a major problem in the diagnostics of oncological patients, Eur J Nucl Med, 23, 1409-15, 1996
DOI
|
3 |
Cook GJ, Fogelman I, Maisey MN: Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation, Semin Nucl Med, 26, 308-314, 1996
DOI
|
4 |
Shreve PD, Anzai Y, Wahl R: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants, Radiographics, 19, 61-77, 1999
DOI
|
5 |
Cook GJ, Wegner EA, Fogelman I: Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine, Eur J Nucl Med Mol Imaging, 26, 1363-1378, 1999
DOI
|
6 |
Blodgett TM, Fukui MB, Snyderman CH, et al: Combined PET-CT in the head and neck: part 1-physiologic, altered physiologic, and artifactual FDG uptake, Radiographics, 25, 897-912, 2005
DOI
|
7 |
Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR: Blake MA, Bowel hot spots at PET-CT, Radiographics, 27, 145-159, 2007
DOI
|
8 |
Mijin Yun, Arthur Cho, Jae Hoon Lee, Yun-Jung Choi, Jong Doo Lee, and Chun K. Kim: Physiologic 18F-FDGUptakeintheFallopianTubes at Mid Cycle on PET/CT, J Nucl Med, 51, 682-685, 2010
DOI
|
9 |
Treloar, A. E.; Boyton, R. E.; Behn, B. G.; and Brown, B. W: Variations of the Human Menstrual Cycle through Reproductive Life, International Journal of Fertility, 9, 77-126, 1967
|
10 |
Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F: PET/CT and breast cancer, Eur J Nucl Med Mol Imaging, 31(suppl 1), 135-142, 2004
DOI
|
11 |
Tatsumi M, Cohade C, Mourtzikos KA, Fishman EK, Wahl RL: Initial experience with FDG-PET/CT in the evaluation of breast cancer, Eur J Nucl Med Mol Imaging, 33, 254-262, 2006
DOI
|
12 |
Kerlikowske K, Grady D, Barclay J, et al: Effect of age, breast density, and family history on the sensitivity of first screening mammography, JAMA, 276, 33-38, 1996
DOI
|
13 |
Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O: The role of FDG-PET/CT in suspected recurrence of breast cancer, Cancer, 107, 2545-2551, 2006
DOI
|
14 |
Beresford M, Lyburn I , Sanghera B, Makris A, Wong WL: Serial integrated 18F fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma, Breast J, 13, 424-425, 2007
DOI
|
15 |
Rosenberg RD, Hunt WC, Williamson MR, et al: Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico, Radiology, 209, 511, 1998
DOI
|
16 |
Kavanagh AM, Cawson J , Byrnes G B, et al: Hormone replacement therapy, percent mammographic density, and sensitivity of mammography, Cancer Epidemiol Biomarkers Prev, 14, 1060-1064, 2005
DOI
|